Physician profile
Daniel Opheim
NPI 1295821569
$2,505.22
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,823 · 2020: $194 · 2021: $238 · 2022: $250.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,950.98 | 2019-2022 | |
| Conmed Corporation | $107.14 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $95.98 | 2021 | |
| Ethicon US, LLC | $63.57 | 2020-2021 | |
| Axonics, INC. | $59.07 | 2020-2021 | |
| Medtronic, INC. | $47.99 | 2021-2022 | |
| Braintree Laboratories, INC. | $24.86 | 2021-2022 | |
| Thd America, INC. | $23.54 | 2020-2021 | |
| Baxter Healthcare | $23.07 | 2021-2022 | |
| Ferring Pharmaceuticals INC. | $18.00 | 2021 | |
| Covidien LP | $16.60 | 2020 | |
| Medtronic USA, INC. | $16.52 | 2020 | |
| Sanara Medtech INC. | $16.11 | 2022 | |
| Boston Scientific Corporation | $15.01 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $13.43 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zyla Life Sciences, INC. | $13.35 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Opheim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.